These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17630014)
1. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. Zhou X; Liu B; Yu X; Zha X; Zhang X; Chen Y; Wang X; Jin Y; Wu Y; Chen Y; Shan Y; Chen Y; Liu J; Kong W; Shen J J Control Release; 2007 Aug; 121(3):200-7. PubMed ID: 17630014 [TBL] [Abstract][Full Text] [Related]
2. Controlled release of PEI/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime/MVA boost regime. Zhou X; Liu B; Yu X; Zha X; Zhang X; Wang X; Jin Y; Wu Y; Chen Y; Shan Y; Chen Y; Liu J; Kong W; Shen J Eur J Pharm Biopharm; 2008 Mar; 68(3):589-95. PubMed ID: 17950586 [TBL] [Abstract][Full Text] [Related]
3. Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly. Zhou X; Liu B; Yu X; Zha X; Zhang X; Wang X; Chen Y; Chen Y; Chen Y; Shan Y; Jin Y; Wu Y; Liu J; Kong W; Shen J Biomaterials; 2007 Nov; 28(31):4684-92. PubMed ID: 17686512 [TBL] [Abstract][Full Text] [Related]
4. Cationic microparticles: A potent delivery system for DNA vaccines. Singh M; Briones M; Ott G; O'Hagan D Proc Natl Acad Sci U S A; 2000 Jan; 97(2):811-6. PubMed ID: 10639162 [TBL] [Abstract][Full Text] [Related]
5. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine. Layek B; Lipp L; Singh J J Control Release; 2015 Jun; 207():143-53. PubMed ID: 25886704 [TBL] [Abstract][Full Text] [Related]
6. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907 [TBL] [Abstract][Full Text] [Related]
7. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses. Orson FM; Kinsey BM; Hua PJ; Bhogal BS; Densmore CL; Barry MA J Immunol; 2000 Jun; 164(12):6313-21. PubMed ID: 10843685 [TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine. Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875 [TBL] [Abstract][Full Text] [Related]
9. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant. Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475 [TBL] [Abstract][Full Text] [Related]
10. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Woo PC; Wong LP; Zheng BJ; Yuen KY Vaccine; 2001 Apr; 19(20-22):2945-54. PubMed ID: 11282206 [TBL] [Abstract][Full Text] [Related]
11. Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells. Geng S; Zhong Y; Wang S; Liu H; Zou Q; Xie X; Li C; Yu Q; He Z; Wang B PLoS One; 2012; 7(3):e33015. PubMed ID: 22438887 [TBL] [Abstract][Full Text] [Related]
12. A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model. Zheng B; Woo PC; Ng M; Tsoi H; Wong L; Yuen K Vaccine; 2001 Oct; 20(1-2):140-7. PubMed ID: 11567758 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine). Nguyen DN; Raghavan SS; Tashima LM; Lin EC; Fredette SJ; Langer RS; Wang C Biomaterials; 2008 Jun; 29(18):2783-93. PubMed ID: 18400294 [TBL] [Abstract][Full Text] [Related]
14. [Effects of cell-mediated immunity induced by intramuscular chitosan-pJME/ GM-CSF nano-DNA vaccine in BAlb/c mice]. Zhai YZ; Zhou Y; Ma L; Feng GH Bing Du Xue Bao; 2014 Jul; 30(4):423-8. PubMed ID: 25272598 [TBL] [Abstract][Full Text] [Related]
15. Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide. Schirmbeck R; König-Merediz SA; Riedl P; Kwissa M; Sack F; Schroff M; Junghans C; Reimann J; Wittig B J Mol Med (Berl); 2001 Jun; 79(5-6):343-50. PubMed ID: 11485031 [TBL] [Abstract][Full Text] [Related]
16. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice. Li X; Yang X; Jiang Y; Liu J Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237 [TBL] [Abstract][Full Text] [Related]
17. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545 [TBL] [Abstract][Full Text] [Related]
18. Enhanced humoral and cell-mediated immune responses generated by cationic polymer-coated PLA microspheres with adsorbed HBsAg. Chen X; Liu Y; Wang L; Liu Y; Zhang W; Fan B; Ma X; Yuan Q; Ma G; Su Z Mol Pharm; 2014 Jun; 11(6):1772-84. PubMed ID: 24738485 [TBL] [Abstract][Full Text] [Related]
19. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J; Grusby MJ; Schirmbeck R; Reimann J J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922 [TBL] [Abstract][Full Text] [Related]
20. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice. Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]